glp 1 issues GLP-1 and Anesthesia: Considerations and Cautions for CRNAs GLP-1 Drugs, Digital Health &

Incretin mimetics considerably expanded their proven benefits beyond obesity in 2024

Understanding why provider guidance matters helps patients access these medications responsibly through appropriate channels

What to eat to balance your blood sugar and lose weight

Smart, protein-rich meals when appetite feels different.

Recent studies have highlighted the effectiveness ofweight loss medications, particularly GLP-1 agonists like Semaglutide (found in Wegovy and Ozempic) and Tirzepatide (found []

Link to full post: GLP-1 Drugs, Digital Health & Obesity Trends in 2026Overweight and obesity are driving a booming digital health market through telehealth, wearables, and new pharma-to-consumer models.I've been reporting on this space in my #Trends report since March 2024two years ago (Navigating Obesity Care in the Digital Age)